A potent and orally active HIV-1 integrase inhibitor

被引：24

作者：

Egbertson, Melissa S. ^{[1
]}

Moritz, H. Marie

Melamed, Jeffrey Y.

Han, Wei

Perlow, Debra S.

Kuo, Michelle S.

Embrey, Mark

Vacca, Joseph P.

Zrada, Matthew M.

Cortes, Amanda R.

Wallace, Audrey

Leonard, Yvonne

Hazuda, Daria J.

Miller, Michael D.

Felock, Peter J.

Stillmock, Kara A.

Witmer, Marc V.

Schleif, William

Gabryelski, Lori J.

Moyer, Gregory

Ellis, Joan D.

Jin, Lixia

Xu, Wei

Braun, Matthew P.

Kassahun, Kellem

Tsou, Nancy N.

Young, Steven D.

机构：

[1] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA

[2] Merck Res Labs, Dept Biol Chem, West Point, PA 19486 USA

[3] Merck Res Labs, Dept Viral Vaccine Res, West Point, PA 19486 USA

[4] Merck Res Labs, Pharmaceut Res Dept, West Point, PA 19486 USA

[5] Merck Res Labs, Dept Drug Metab, West Point, PA 19486 USA

[6] Dept Med Chem, Rahway, NJ 07065 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 05期

关键词：

HIV; AIDS; integrase; strand transfer; 1,6-naphthyridine;

D O I：

10.1016/j.bmcl.2006.11.080

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A 1,6-naphthyridine inhibitor of HIV-1 integrase has been discovered with excellent inhibitory activity in cells, good pharmacokinetics, and an excellent ability to inhibit virus with mutant enzyme. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：1392 / 1398

页数：7

共 50 条

[1] Asymmetric Synthesis of a Potent HIV-1 Integrase Inhibitor
Kuethe, Jeffrey T.
Humphrey, Guy R.
Journet, Michel
Peng, Zhihui
Childers, Karla G.
JOURNAL OF ORGANIC CHEMISTRY, 2016, 81 (21): : 10256 - 10265
[2] HIV-1 integrase inhibitor
Lloyd, AW
DRUG DISCOVERY TODAY, 1996, 1 (04) : 170 - 170
[3] Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitors
Muraglia, Ester
Kinzel, Olaf
Gardelli, Cristina
Crescenzi, Benedetta
Donghi, Monica
Ferrara, Marco
Nizi, Emanuela
Orvieto, Federica
Pescatore, Giovanna
Laufer, Ralph
Gonzalez-Paz, Odalys
Di Marco, Annalise
Fiore, Fabrizio
Monteagudo, Edith
Fonsi, Massimiliano
Felock, Peter J.
Rowley, Michael
Summa, Vincenzo
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) : 861 - 874
[4] Raltegravir: an integrase inhibitor for HIV-1
Evering, Teresa H.
Markowitz, Martin
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (03) : 413 - 422
[5] Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors
Li, Guo
Meanwell, Nicholas A.
Krystal, Mark R.
Langley, David R.
Naidu, B. Narasimhulu
Sivaprakasam, Prasanna
Lewis, Hal
Kish, Kevin
Khan, Javed A.
Ng, Alicia
Trainor, George L.
Cianci, Christopher
Dicker, Ira B.
Walker, Michael A.
Lin, Zeyu
Protack, Tricia
Discotto, Linda
Jenkins, Susan
Gerritz, Samuel W.
Pendri, Annapurna
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (05) : 2620 - 2637
[6] Raltegravir, an HIV-1 integrase inhibitor for HIV infection
Cabrera, Cecilia
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (08) : 885 - 898
[7] Expeditious Synthesis of a Potent Allosteric HIV-1 Integrase Inhibitor GSK3839919A
Bobko, Mark A.
Elward, Jennifer M.
Naidu, B. Narasimhulu
Nieves-Quinones, Yexenia E.
Reiher, Christopher A.
Su, Qiaogong
Sun, Liang
Woodard, John
Xie, Shiping
Yang, Wuxing
Yin, Yunxing
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2023, : 217 - 226
[8] QSAR Study on Diketo Acid and Carboxamide Derivatives as Potent HIV-1 Integrase Inhibitor
Adebimpe, Arodola Olayide
Dash, Radha Charan
Soliman, Mahmoud E. S.
LETTERS IN DRUG DESIGN & DISCOVERY, 2014, 11 (05) : 618 - 627
[9] Bictegravir HIV integrase inhibitor, Treatment of HIV-1 infection
Cole, P.
DRUGS OF THE FUTURE, 2017, 42 (09) : 541 - 547
[10] An interlocked dimeric parallel-stranded DNA quadruplex:: A potent inhibitor of HIV-1 integrase
Phan, AT
Kuryavyi, V
Ma, JB
Faure, A
Andréola, ML
Patel, DJ
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) : 634 - 639

← 1 2 3 4 5 →